| Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model O Akil, F Dyka, C Calvet, A Emptoz, G Lahlou, S Nouaille, ... Proceedings of the National Academy of Sciences 116 (10), 4496-4501, 2019 | 249 | 2019 |
| Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors CN Kay, RC Ryals, GV Aslanidi, SH Min, Q Ruan, J Sun, FM Dyka, ... PloS one 8 (4), e62097, 2013 | 202 | 2013 |
| Transcription of glycolytic genes and operons in Bacillus subtilis: evidence for the presence of multiple levels of control of the gapA operon H Ludwig, G Homuth, M Schmalisch, FM Dyka, M Hecker, J Stülke Molecular Microbiology 41 (2), 409-422, 2001 | 194 | 2001 |
| Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus VS Lopes, SE Boye, CM Louie, S Boye, F Dyka, V Chiodo, H Fofo, ... Gene therapy 20 (8), 824-833, 2013 | 164 | 2013 |
| Dual Adeno-Associated Virus Vectors Result in Efficient In Vitro and In Vivo Expression of an Oversized Gene, MYO7A FM Dyka, SL Boye, VA Chiodo, WW Hauswirth, SE Boye Human gene therapy methods 25 (2), 166-177, 2014 | 134 | 2014 |
| Long-term preservation of cone photoreceptors and restoration of cone function by gene therapy in the guanylate cyclase-1 knockout (GC1KO) mouse SL Boye, T Conlon, K Erger, R Ryals, A Neeley, T Cossette, J Pang, ... Investigative ophthalmology & visual science 52 (10), 7098-7108, 2011 | 80 | 2011 |
| Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness ML Scalabrino, SL Boye, KMH Fransen, JM Noel, FM Dyka, SH Min, ... Human molecular genetics 24 (21), 6229-6239, 2015 | 79 | 2015 |
| AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis SL Boye, IV Peshenko, WC Huang, SH Min, I McDoom, CN Kay, X Liu, ... Human gene therapy 24 (2), 189-202, 2013 | 74 | 2013 |
| Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with adeno-associated viral vectors CN De Leeuw, FM Dyka, SL Boye, S Laprise, M Zhou, AY Chou, ... Molecular therapy Methods & clinical development 1, 2014 | 72 | 2014 |
| Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa WT Deng, FM Dyka, A Dinculescu, J Li, P Zhu, VA Chiodo, SL Boye, ... Human gene therapy 26 (9), 593-602, 2015 | 67 | 2015 |
| Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin S Walia, GA Fishman, RS Molday, FM Dyka, NM Kumar, MA Ehlinger, ... American journal of ophthalmology 147 (1), 111-115. e1, 2009 | 67 | 2009 |
| Dual ABCA4-AAV Vector Treatment Reduces Pathogenic Retinal A2E Accumulation in a Mouse Model of Autosomal Recessive Stargardt Disease FM Dyka, LL Molday, VA Chiodo, RS Molday, WW Hauswirth Human gene therapy 30 (11), 1361-1370, 2019 | 52 | 2019 |
| Metabotropic glutamate receptors are differentially regulated under elevated intraocular pressure FM Dyka, CA May, R Enz Journal of Neurochemistry 90 (1), 190-202, 2004 | 46 | 2004 |
| Interaction and localization of the retinitis pigmentosa protein RP2 and NSF in retinal photoreceptor cells JM Holopainen, CL Cheng, LL Molday, G Johal, J Coleman, F Dyka, T Hii, ... Biochemistry 49 (35), 7439-7447, 2010 | 43 | 2010 |
| Methods and compositions for gene delivery to on bipolar cells SE Boye, F Dyka, SL Boye, WW Hauswirth US Patent App. 15/120,425, 2017 | 40 | 2017 |
| Coexpression and interaction of wild-type and missense RS1 mutants associated with X-linked retinoschisis: its relevance to gene therapy FM Dyka, RS Molday Investigative ophthalmology & visual science 48 (6), 2491-2497, 2007 | 32 | 2007 |
| Subunits of the epithelial sodium channel family are differentially expressed in the retina of mice with ocular hypertension FM Dyka, CA May, R Enz Journal of neurochemistry 94 (1), 120-128, 2005 | 29 | 2005 |
| Cholesterol transport via ABCA1: new insights from solid-phase binding assay E Reboul, FM Dyka, F Quazi, RS Molday Biochimie 95 (4), 957-961, 2013 | 28 | 2013 |
| Cone specific promoter for use in gene therapy of retinal degenerative diseases FM Dyka, SL Boye, RC Ryals, VA Chiodo, SE Boye, WW Hauswirth Retinal Degenerative Diseases: Mechanisms and Experimental Therapy, 695-701, 2014 | 27 | 2014 |
| Characterization and purification of the discoidin domain-containing protein retinoschisin and its interaction with galactose FM Dyka, WWH Wu, TA Pfeifer, LL Molday, TA Grigliatti, RS Molday Biochemistry 47 (35), 9098-9106, 2008 | 25 | 2008 |
Sanford L. BoyePowell Gene Therapy Center, Department of Pediatrics, University of FloridaEmail verificata su ufl.edu
